- Home
- SNAX
SNAX
Stryve Foods Inc.
as 07-26-2024 4:00pm EST
Stryve Foods Inc is a healthy snacking company which manufactures, markets and sells highly differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | PLANO |
| Market Cap: | 5.5M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 7.9K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.04 - $4.92 | Next Earning Date: | 08-12-2024 |
| Revenue: | $17,662,350 | Revenue Growth: | -35.00% |
| Revenue Growth (this year): | 47.87% | Revenue Growth (next year): | N/A |
Latest Stryve Foods Inc. News
SNAX Breaking Stock News: Dive into SNAX Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 days ago
Stryve Foods Insiders Are Down US$129k But Regain Some Losses
GlobeNewswire
23 days ago
Stryve Foods Appoints Former Frito-Lay Executive as Chairman
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
2 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Business Wire
2 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
Compare SNAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNAX Stryve Foods Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.